BIAF
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.97
−6.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.01x
- Price / sales
- 0.65x
- Price / cash flow
- -0.33x
Enterprise value
- Enterprise value
- $2.8M
- EV / sales
- 0.48x
- EV / EBITDA
- -0.19x
- EV / EBIT
- -0.23x
- Market cap
- $3.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026